Tumor-specific activation coupled with protection of normal tissues by utilizing tetrahydrouridine in combination with a novel antineoplastic prodrug, 5-trifluoromethyldeoxycytidine: A new concept in chemotherapy

D. A. Boothman, S. Greer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)No. 523
JournalFederation Proceedings
Issue number3
StatePublished - Jan 1 1985

ASJC Scopus subject areas

  • Medicine(all)

Cite this